Journal of Thrombosis and Thrombolysis

Papers
(The H4-Index of Journal of Thrombosis and Thrombolysis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database49
Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity45
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection45
Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery34
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia34
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team29
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry28
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment28
Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors24
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians24
Management of bone marrow biopsy related bleeding risks: a retrospective observational study24
Direct oral anticoagulants for secondary stroke prevention in patients over 80 years of age: the role of geriatric functional status23
Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate22
HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia21
Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic20
Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer19
Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPA18
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone17
Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals17
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series17
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy17
0.061293840408325